| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bone Marrow Cells | 30 | 2019 | 2414 | 3.610 |
Why?
|
| Osteoblasts | 23 | 2021 | 1153 | 2.900 |
Why?
|
| Mesenchymal Stem Cells | 18 | 2021 | 1672 | 2.650 |
Why?
|
| Chondrocytes | 17 | 2015 | 800 | 2.260 |
Why?
|
| Calcifediol | 7 | 2019 | 160 | 2.070 |
Why?
|
| Bone Transplantation | 31 | 2015 | 925 | 1.900 |
Why?
|
| Osteoclasts | 24 | 2014 | 713 | 1.740 |
Why?
|
| Osteogenesis | 34 | 2020 | 1295 | 1.740 |
Why?
|
| Vitamin D | 16 | 2021 | 3311 | 1.560 |
Why?
|
| Stromal Cells | 14 | 2019 | 1337 | 1.490 |
Why?
|
| Collagen | 29 | 2010 | 2646 | 1.290 |
Why?
|
| Cell Differentiation | 38 | 2021 | 11684 | 1.270 |
Why?
|
| Bone and Bones | 28 | 2014 | 2590 | 1.170 |
Why?
|
| Parathyroid Hormone | 8 | 2015 | 1803 | 1.120 |
Why?
|
| Chondrogenesis | 8 | 2012 | 239 | 1.100 |
Why?
|
| Cartilage | 13 | 2005 | 811 | 1.070 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 5 | 2020 | 57 | 1.010 |
Why?
|
| Bone Demineralization Technique | 10 | 2015 | 27 | 0.990 |
Why?
|
| Osteoporosis | 8 | 2018 | 1606 | 0.970 |
Why?
|
| Mandible | 12 | 2007 | 759 | 0.900 |
Why?
|
| Osteoarthritis, Hip | 4 | 2011 | 409 | 0.900 |
Why?
|
| Dehydroepiandrosterone | 5 | 2018 | 259 | 0.890 |
Why?
|
| Osteogenesis, Distraction | 9 | 2010 | 238 | 0.870 |
Why?
|
| Tissue Engineering | 8 | 2009 | 1893 | 0.870 |
Why?
|
| Bone Resorption | 20 | 2017 | 728 | 0.860 |
Why?
|
| Bone Matrix | 7 | 2009 | 127 | 0.790 |
Why?
|
| Transforming Growth Factor beta | 8 | 2009 | 2004 | 0.780 |
Why?
|
| Fibroblasts | 15 | 2012 | 4179 | 0.780 |
Why?
|
| Biocompatible Materials | 11 | 2005 | 1703 | 0.740 |
Why?
|
| Bone Density | 15 | 2018 | 3574 | 0.730 |
Why?
|
| Surgery, Oral | 1 | 2022 | 133 | 0.700 |
Why?
|
| Rodentia | 1 | 2021 | 262 | 0.690 |
Why?
|
| Aging | 17 | 2014 | 8745 | 0.680 |
Why?
|
| Cells, Cultured | 37 | 2021 | 19023 | 0.640 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2012 | 344 | 0.640 |
Why?
|
| Cartilage, Articular | 5 | 2015 | 1104 | 0.630 |
Why?
|
| Alendronate | 2 | 2011 | 174 | 0.620 |
Why?
|
| Bone Morphogenetic Proteins | 5 | 2015 | 847 | 0.620 |
Why?
|
| Tissue Scaffolds | 3 | 2009 | 951 | 0.590 |
Why?
|
| Fracture Healing | 4 | 2015 | 448 | 0.560 |
Why?
|
| Extracellular Matrix Proteins | 7 | 2009 | 835 | 0.560 |
Why?
|
| Bone Regeneration | 5 | 2009 | 446 | 0.550 |
Why?
|
| Absorptiometry, Photon | 5 | 2011 | 1758 | 0.550 |
Why?
|
| Receptor, Parathyroid Hormone, Type 1 | 2 | 2015 | 305 | 0.530 |
Why?
|
| Tibia | 5 | 2014 | 1076 | 0.520 |
Why?
|
| Osteoporosis, Postmenopausal | 6 | 2011 | 399 | 0.520 |
Why?
|
| Tissue Preservation | 3 | 2015 | 173 | 0.510 |
Why?
|
| Insulin-Like Growth Factor I | 8 | 2018 | 1943 | 0.510 |
Why?
|
| Radiation Injuries | 2 | 2021 | 1203 | 0.500 |
Why?
|
| Leptin | 3 | 2021 | 1597 | 0.500 |
Why?
|
| Vitamin D Deficiency | 5 | 2008 | 1388 | 0.480 |
Why?
|
| Wound Healing | 13 | 2021 | 2815 | 0.480 |
Why?
|
| Receptors, Calcitriol | 5 | 2020 | 361 | 0.480 |
Why?
|
| Bone Substitutes | 4 | 2001 | 233 | 0.480 |
Why?
|
| Estradiol | 3 | 2017 | 1952 | 0.480 |
Why?
|
| Gene Expression Regulation | 8 | 2017 | 11932 | 0.470 |
Why?
|
| Osteocalcin | 10 | 1999 | 277 | 0.440 |
Why?
|
| Cattle | 13 | 2012 | 3819 | 0.440 |
Why?
|
| Osteoarthritis | 2 | 2015 | 1070 | 0.440 |
Why?
|
| Jaw Abnormalities | 2 | 2013 | 27 | 0.440 |
Why?
|
| RANK Ligand | 2 | 2014 | 321 | 0.420 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2020 | 2297 | 0.420 |
Why?
|
| Maxillofacial Development | 1 | 2013 | 88 | 0.420 |
Why?
|
| Adipocytes | 5 | 2011 | 1199 | 0.420 |
Why?
|
| Jaw | 1 | 2013 | 95 | 0.420 |
Why?
|
| Osseointegration | 4 | 2011 | 277 | 0.410 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2011 | 500 | 0.390 |
Why?
|
| Hip Fractures | 4 | 2011 | 997 | 0.380 |
Why?
|
| Cell Culture Techniques | 10 | 2005 | 1667 | 0.380 |
Why?
|
| Bone Density Conservation Agents | 2 | 2009 | 797 | 0.370 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2012 | 642 | 0.360 |
Why?
|
| Collagen Type II | 3 | 2006 | 151 | 0.360 |
Why?
|
| Femur Neck | 2 | 2010 | 318 | 0.360 |
Why?
|
| Ilium | 2 | 2010 | 155 | 0.360 |
Why?
|
| Sex Characteristics | 2 | 2013 | 2649 | 0.350 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 3 | 2006 | 142 | 0.350 |
Why?
|
| Wnt Proteins | 3 | 2011 | 725 | 0.350 |
Why?
|
| Gene Expression | 12 | 2019 | 7603 | 0.350 |
Why?
|
| Estrogens | 4 | 2001 | 1536 | 0.340 |
Why?
|
| Lectins, C-Type | 4 | 2006 | 593 | 0.340 |
Why?
|
| Signal Transduction | 11 | 2012 | 23653 | 0.330 |
Why?
|
| Alveolar Bone Loss | 1 | 2013 | 401 | 0.330 |
Why?
|
| Radiation Tolerance | 1 | 2012 | 478 | 0.330 |
Why?
|
| Fractures, Spontaneous | 2 | 2008 | 232 | 0.330 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2020 | 3612 | 0.320 |
Why?
|
| Prostheses and Implants | 7 | 2010 | 1279 | 0.320 |
Why?
|
| Animals | 89 | 2021 | 169335 | 0.320 |
Why?
|
| Biomedical Engineering | 2 | 2001 | 286 | 0.320 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 9 | 2012 | 4592 | 0.310 |
Why?
|
| Powders | 10 | 2005 | 79 | 0.310 |
Why?
|
| Postmenopause | 8 | 2007 | 2519 | 0.310 |
Why?
|
| Culture Media | 5 | 2019 | 898 | 0.300 |
Why?
|
| RNA, Small Interfering | 6 | 2019 | 3433 | 0.300 |
Why?
|
| Oral Surgical Procedures | 2 | 2007 | 172 | 0.280 |
Why?
|
| Extracellular Matrix | 5 | 2005 | 1739 | 0.270 |
Why?
|
| Steroid Hydroxylases | 3 | 2011 | 93 | 0.270 |
Why?
|
| Interleukin-1 | 4 | 2005 | 1251 | 0.270 |
Why?
|
| Rats | 33 | 2021 | 23786 | 0.270 |
Why?
|
| Skin | 8 | 2021 | 4506 | 0.270 |
Why?
|
| Dermis | 2 | 2005 | 203 | 0.270 |
Why?
|
| Alkaline Phosphatase | 7 | 2012 | 864 | 0.250 |
Why?
|
| Nicotinic Agonists | 1 | 2007 | 265 | 0.250 |
Why?
|
| Blood Substitutes | 1 | 2005 | 57 | 0.250 |
Why?
|
| Humans | 97 | 2022 | 768970 | 0.250 |
Why?
|
| Calcium, Dietary | 1 | 2008 | 533 | 0.240 |
Why?
|
| Hematopoiesis | 3 | 2012 | 2059 | 0.240 |
Why?
|
| Interleukin-6 | 6 | 2018 | 3232 | 0.240 |
Why?
|
| Regeneration | 4 | 2003 | 1524 | 0.240 |
Why?
|
| Osteoprotegerin | 3 | 2014 | 179 | 0.240 |
Why?
|
| Polymorphism, Genetic | 1 | 2015 | 4251 | 0.240 |
Why?
|
| Cranial Sutures | 2 | 2004 | 99 | 0.230 |
Why?
|
| Aggrecans | 4 | 2006 | 89 | 0.230 |
Why?
|
| Estrogen Receptor alpha | 3 | 2017 | 581 | 0.230 |
Why?
|
| Sterilization | 1 | 2005 | 132 | 0.230 |
Why?
|
| Skull | 8 | 2012 | 830 | 0.220 |
Why?
|
| Wounds and Injuries | 2 | 2014 | 2517 | 0.220 |
Why?
|
| Bioprosthesis | 2 | 2008 | 593 | 0.220 |
Why?
|
| Macrophage Colony-Stimulating Factor | 2 | 2014 | 187 | 0.220 |
Why?
|
| Acid Phosphatase | 9 | 2007 | 141 | 0.220 |
Why?
|
| Aged | 32 | 2020 | 171786 | 0.220 |
Why?
|
| Female | 64 | 2020 | 397515 | 0.210 |
Why?
|
| Hindlimb | 2 | 2010 | 516 | 0.210 |
Why?
|
| Craniosynostoses | 3 | 2004 | 416 | 0.210 |
Why?
|
| Nicotine | 1 | 2007 | 680 | 0.200 |
Why?
|
| Male | 65 | 2021 | 365203 | 0.200 |
Why?
|
| Internship and Residency | 1 | 2022 | 5956 | 0.200 |
Why?
|
| Craniotomy | 4 | 2012 | 747 | 0.190 |
Why?
|
| Osteitis | 1 | 2001 | 33 | 0.190 |
Why?
|
| Calcitriol | 3 | 2012 | 303 | 0.190 |
Why?
|
| Swine, Miniature | 7 | 2010 | 965 | 0.190 |
Why?
|
| Dihydrotestosterone | 1 | 2001 | 195 | 0.180 |
Why?
|
| Trans-Activators | 3 | 2005 | 2858 | 0.180 |
Why?
|
| Dental Restoration Failure | 1 | 2001 | 156 | 0.180 |
Why?
|
| Proteoglycans | 5 | 2005 | 809 | 0.180 |
Why?
|
| Fractures, Ununited | 2 | 1999 | 176 | 0.180 |
Why?
|
| Middle Aged | 35 | 2020 | 223737 | 0.180 |
Why?
|
| Hip Joint | 1 | 2007 | 1018 | 0.170 |
Why?
|
| Stem Cells | 4 | 2011 | 3539 | 0.170 |
Why?
|
| Polyglycolic Acid | 1 | 2001 | 408 | 0.170 |
Why?
|
| Gene Expression Profiling | 4 | 2011 | 9549 | 0.170 |
Why?
|
| Bone Screws | 1 | 2003 | 534 | 0.170 |
Why?
|
| Lower Extremity | 2 | 2008 | 1217 | 0.170 |
Why?
|
| Bone Cysts | 1 | 1999 | 48 | 0.160 |
Why?
|
| Genotype | 1 | 2014 | 13048 | 0.160 |
Why?
|
| Estrogen Replacement Therapy | 4 | 2001 | 1209 | 0.160 |
Why?
|
| Mandibular Advancement | 3 | 2004 | 64 | 0.160 |
Why?
|
| Fibrous Dysplasia of Bone | 1 | 1999 | 53 | 0.160 |
Why?
|
| Joints | 1 | 2001 | 324 | 0.160 |
Why?
|
| Hemangioma | 5 | 1986 | 727 | 0.160 |
Why?
|
| Ossification, Heterotopic | 1 | 2001 | 240 | 0.160 |
Why?
|
| Fractures, Bone | 3 | 2002 | 2063 | 0.150 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2005 | 3810 | 0.150 |
Why?
|
| Mice, SCID | 3 | 2014 | 2631 | 0.150 |
Why?
|
| Blotting, Western | 3 | 2011 | 5033 | 0.150 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2017 | 58 | 0.140 |
Why?
|
| Methylmethacrylates | 2 | 1988 | 67 | 0.140 |
Why?
|
| Hyaluronic Acid | 1 | 2001 | 488 | 0.140 |
Why?
|
| Chick Embryo | 4 | 2004 | 975 | 0.140 |
Why?
|
| Obesity | 1 | 2019 | 13091 | 0.140 |
Why?
|
| Flavonols | 1 | 2017 | 85 | 0.140 |
Why?
|
| Connective Tissue Cells | 1 | 1996 | 50 | 0.140 |
Why?
|
| Bone Remodeling | 3 | 2009 | 583 | 0.140 |
Why?
|
| Parietal Bone | 2 | 2011 | 49 | 0.130 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2011 | 1169 | 0.130 |
Why?
|
| Lactic Acid | 1 | 2001 | 1140 | 0.130 |
Why?
|
| Activin Receptors, Type II | 1 | 2017 | 123 | 0.130 |
Why?
|
| Mice | 20 | 2021 | 82072 | 0.130 |
Why?
|
| Oligopeptides | 1 | 2001 | 1194 | 0.130 |
Why?
|
| Porosity | 2 | 2008 | 352 | 0.130 |
Why?
|
| Fingers | 2 | 1992 | 512 | 0.130 |
Why?
|
| Adult | 28 | 2022 | 223851 | 0.130 |
Why?
|
| Up-Regulation | 4 | 2008 | 4148 | 0.120 |
Why?
|
| Arthroplasty, Replacement, Hip | 2 | 2003 | 1421 | 0.120 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2000 | 859 | 0.120 |
Why?
|
| Calcitonin | 2 | 1988 | 329 | 0.120 |
Why?
|
| Connective Tissue | 4 | 2010 | 425 | 0.120 |
Why?
|
| Tissue Banks | 1 | 1996 | 184 | 0.120 |
Why?
|
| Aged, 80 and over | 13 | 2020 | 59739 | 0.120 |
Why?
|
| beta Catenin | 3 | 2011 | 1047 | 0.120 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2014 | 79 | 0.120 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2014 | 94 | 0.120 |
Why?
|
| MAP Kinase Signaling System | 2 | 2016 | 1495 | 0.120 |
Why?
|
| Polymers | 1 | 2001 | 1632 | 0.110 |
Why?
|
| Osteosarcoma | 2 | 1999 | 911 | 0.110 |
Why?
|
| Minerals | 4 | 1987 | 282 | 0.110 |
Why?
|
| Sex Factors | 3 | 2015 | 10633 | 0.110 |
Why?
|
| Puberty | 1 | 2017 | 501 | 0.110 |
Why?
|
| Chondroitin Sulfates | 4 | 2005 | 174 | 0.110 |
Why?
|
| Fibroblast Growth Factors | 1 | 2020 | 873 | 0.110 |
Why?
|
| Maxilla | 2 | 2010 | 489 | 0.110 |
Why?
|
| Hydroxyapatites | 2 | 1990 | 73 | 0.110 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2016 | 384 | 0.110 |
Why?
|
| Age Factors | 5 | 2017 | 18435 | 0.110 |
Why?
|
| RNA, Messenger | 8 | 2006 | 12806 | 0.110 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 1994 | 892 | 0.110 |
Why?
|
| Receptors, Fc | 1 | 2017 | 538 | 0.110 |
Why?
|
| Osteotomy | 5 | 2007 | 838 | 0.110 |
Why?
|
| Neovascularization, Physiologic | 2 | 2010 | 1371 | 0.110 |
Why?
|
| Dental Implants | 1 | 2001 | 807 | 0.110 |
Why?
|
| Oxygen | 1 | 2005 | 4272 | 0.110 |
Why?
|
| Recombinant Proteins | 2 | 2015 | 6512 | 0.100 |
Why?
|
| Metacarpus | 1 | 1992 | 37 | 0.100 |
Why?
|
| Blotting, Northern | 3 | 2005 | 1553 | 0.100 |
Why?
|
| Probability | 2 | 2011 | 2483 | 0.100 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2017 | 545 | 0.100 |
Why?
|
| Radiation-Protective Agents | 2 | 2010 | 88 | 0.100 |
Why?
|
| Rats, Inbred Strains | 5 | 2001 | 2087 | 0.100 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 2 | 2009 | 416 | 0.100 |
Why?
|
| RNA-Binding Proteins | 1 | 2001 | 1891 | 0.100 |
Why?
|
| Glycoproteins | 1 | 2000 | 2202 | 0.100 |
Why?
|
| Perfusion | 4 | 2001 | 1402 | 0.100 |
Why?
|
| Cell Proliferation | 4 | 2017 | 10486 | 0.100 |
Why?
|
| Naphthols | 1 | 2011 | 46 | 0.100 |
Why?
|
| Tyrphostins | 1 | 2011 | 63 | 0.100 |
Why?
|
| Calcification, Physiologic | 3 | 2012 | 171 | 0.100 |
Why?
|
| Simian immunodeficiency virus | 1 | 2017 | 814 | 0.100 |
Why?
|
| Cephalometry | 3 | 2010 | 380 | 0.090 |
Why?
|
| Cell Separation | 2 | 2017 | 1728 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 4528 | 0.090 |
Why?
|
| Osteopetrosis | 2 | 1989 | 42 | 0.090 |
Why?
|
| Cytokines | 4 | 2011 | 7453 | 0.090 |
Why?
|
| Maleimides | 1 | 2011 | 112 | 0.090 |
Why?
|
| Models, Animal | 3 | 2010 | 2122 | 0.090 |
Why?
|
| Safety | 1 | 2015 | 1161 | 0.090 |
Why?
|
| DNA-Binding Proteins | 2 | 2005 | 9618 | 0.090 |
Why?
|
| Calcium-Binding Proteins | 4 | 1997 | 1083 | 0.090 |
Why?
|
| Facial Bones | 2 | 2007 | 209 | 0.090 |
Why?
|
| Glycosaminoglycans | 2 | 2005 | 611 | 0.090 |
Why?
|
| Cyclic N-Oxides | 1 | 2010 | 72 | 0.090 |
Why?
|
| Frontal Bone | 1 | 2011 | 106 | 0.090 |
Why?
|
| Transplantation, Autologous | 4 | 2012 | 2126 | 0.090 |
Why?
|
| Hematopoietic Stem Cells | 5 | 2005 | 3408 | 0.090 |
Why?
|
| Swine | 7 | 2010 | 5997 | 0.090 |
Why?
|
| Microscopy, Electron | 7 | 1991 | 2560 | 0.090 |
Why?
|
| Histocytochemistry | 5 | 2001 | 699 | 0.090 |
Why?
|
| Electroporation | 1 | 2011 | 238 | 0.090 |
Why?
|
| Cell Division | 7 | 2001 | 4478 | 0.090 |
Why?
|
| Foot Joints | 1 | 2010 | 34 | 0.090 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2011 | 282 | 0.080 |
Why?
|
| Ceramics | 1 | 1990 | 113 | 0.080 |
Why?
|
| Cell Survival | 5 | 2012 | 5793 | 0.080 |
Why?
|
| HEK293 Cells | 1 | 2019 | 4290 | 0.080 |
Why?
|
| Isoquinolines | 1 | 2011 | 354 | 0.080 |
Why?
|
| Mice, Inbred NOD | 1 | 2014 | 1839 | 0.080 |
Why?
|
| Disease Models, Animal | 7 | 2021 | 18354 | 0.080 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 1026 | 0.080 |
Why?
|
| Chondroitin | 1 | 2009 | 64 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2021 | 8144 | 0.080 |
Why?
|
| Dehydroepiandrosterone Sulfate | 2 | 2000 | 241 | 0.080 |
Why?
|
| Curriculum | 1 | 2022 | 3782 | 0.080 |
Why?
|
| Tartrates | 4 | 1994 | 13 | 0.080 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2011 | 481 | 0.080 |
Why?
|
| Child | 14 | 2017 | 80960 | 0.080 |
Why?
|
| Osteochondrodysplasias | 2 | 1994 | 183 | 0.080 |
Why?
|
| Arthrodesis | 1 | 2010 | 187 | 0.080 |
Why?
|
| Mast Cells | 3 | 1986 | 1406 | 0.080 |
Why?
|
| Cytoskeletal Proteins | 2 | 2004 | 1328 | 0.070 |
Why?
|
| Biological Assay | 2 | 2005 | 628 | 0.070 |
Why?
|
| Lipoprotein Lipase | 2 | 2005 | 133 | 0.070 |
Why?
|
| Smad3 Protein | 2 | 2005 | 166 | 0.070 |
Why?
|
| Dental Arch | 1 | 2007 | 42 | 0.070 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2009 | 208 | 0.070 |
Why?
|
| Histone Deacetylases | 1 | 2012 | 718 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2001 | 4939 | 0.070 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2009 | 279 | 0.070 |
Why?
|
| Cholecalciferol | 2 | 2012 | 557 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 1999 | 3608 | 0.070 |
Why?
|
| Time Factors | 10 | 2014 | 40261 | 0.070 |
Why?
|
| Materials Testing | 2 | 2001 | 873 | 0.070 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2012 | 778 | 0.070 |
Why?
|
| Arginine Vasopressin | 1 | 2007 | 125 | 0.070 |
Why?
|
| Sialoglycoproteins | 2 | 1999 | 320 | 0.070 |
Why?
|
| Dexamethasone | 2 | 2011 | 1965 | 0.070 |
Why?
|
| Dental Stress Analysis | 2 | 2003 | 66 | 0.070 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2010 | 373 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2011 | 1246 | 0.070 |
Why?
|
| Kinetics | 4 | 2002 | 6332 | 0.070 |
Why?
|
| Osteopontin | 2 | 1999 | 311 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 8 | 2014 | 22379 | 0.060 |
Why?
|
| Diphosphonates | 1 | 2011 | 634 | 0.060 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 2748 | 0.060 |
Why?
|
| Kidney | 3 | 2020 | 7058 | 0.060 |
Why?
|
| Rabbits | 6 | 2012 | 4774 | 0.060 |
Why?
|
| PPAR gamma | 2 | 2005 | 487 | 0.060 |
Why?
|
| Sharks | 1 | 1985 | 21 | 0.060 |
Why?
|
| Radiation Dosage | 1 | 2014 | 1970 | 0.060 |
Why?
|
| Ethylene Oxide | 1 | 2005 | 28 | 0.060 |
Why?
|
| Bone Marrow | 3 | 2017 | 2936 | 0.060 |
Why?
|
| Culture Media, Serum-Free | 1 | 2005 | 148 | 0.060 |
Why?
|
| Vitamin K | 1 | 1987 | 314 | 0.060 |
Why?
|
| Smad2 Protein | 1 | 2005 | 144 | 0.060 |
Why?
|
| Copper | 1 | 1987 | 369 | 0.060 |
Why?
|
| Facial Neoplasms | 1 | 1986 | 126 | 0.060 |
Why?
|
| Arthritis | 1 | 2010 | 684 | 0.060 |
Why?
|
| Manganese | 1 | 1987 | 394 | 0.060 |
Why?
|
| Physical Endurance | 1 | 2007 | 370 | 0.060 |
Why?
|
| Oral Surgical Procedures, Preprosthetic | 1 | 1984 | 28 | 0.060 |
Why?
|
| Cell Adhesion | 3 | 2001 | 3102 | 0.060 |
Why?
|
| Alveolar Ridge Augmentation | 2 | 1984 | 209 | 0.060 |
Why?
|
| Bone Marrow Transplantation | 2 | 2009 | 2709 | 0.060 |
Why?
|
| Hyponatremia | 1 | 2007 | 279 | 0.060 |
Why?
|
| Femoral Fractures | 1 | 2008 | 376 | 0.060 |
Why?
|
| Wnt2 Protein | 1 | 2003 | 28 | 0.060 |
Why?
|
| Receptors, Cell Surface | 2 | 1997 | 2820 | 0.060 |
Why?
|
| Immunohistochemistry | 6 | 2011 | 11116 | 0.060 |
Why?
|
| Polyethylenes | 1 | 1986 | 293 | 0.060 |
Why?
|
| Delayed-Action Preparations | 1 | 2007 | 969 | 0.060 |
Why?
|
| Bone Neoplasms | 1 | 1996 | 2565 | 0.050 |
Why?
|
| Base Sequence | 4 | 2005 | 12430 | 0.050 |
Why?
|
| Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase | 1 | 2003 | 7 | 0.050 |
Why?
|
| Receptors, Collagen | 1 | 2003 | 25 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 6086 | 0.050 |
Why?
|
| Women's Health | 1 | 2013 | 2081 | 0.050 |
Why?
|
| Collagen Type XI | 1 | 2003 | 21 | 0.050 |
Why?
|
| Protamines | 1 | 1983 | 112 | 0.050 |
Why?
|
| Transfection | 1 | 2011 | 5763 | 0.050 |
Why?
|
| Placebos | 1 | 2007 | 1667 | 0.050 |
Why?
|
| Decorin | 1 | 2003 | 38 | 0.050 |
Why?
|
| Periodontal Diseases | 2 | 1984 | 455 | 0.050 |
Why?
|
| Radiography | 5 | 2010 | 6991 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2011 | 2492 | 0.050 |
Why?
|
| Glutathione | 1 | 2005 | 589 | 0.050 |
Why?
|
| Transplantation, Homologous | 5 | 2005 | 4835 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2007 | 1687 | 0.050 |
Why?
|
| Indoles | 1 | 2011 | 1836 | 0.050 |
Why?
|
| Superoxide Dismutase | 1 | 2005 | 595 | 0.050 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2003 | 56 | 0.050 |
Why?
|
| Biopsy | 2 | 2009 | 6805 | 0.050 |
Why?
|
| Cell Line | 4 | 2003 | 15604 | 0.050 |
Why?
|
| Collagen Type III | 1 | 2003 | 92 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 1992 | 2167 | 0.050 |
Why?
|
| Hydrostatic Pressure | 1 | 2002 | 99 | 0.050 |
Why?
|
| Integrin alpha Chains | 1 | 2003 | 93 | 0.050 |
Why?
|
| Running | 1 | 2007 | 490 | 0.050 |
Why?
|
| Reproducibility of Results | 4 | 2010 | 20245 | 0.050 |
Why?
|
| Musculoskeletal Diseases | 1 | 2008 | 599 | 0.050 |
Why?
|
| Jaw Diseases | 1 | 1982 | 91 | 0.050 |
Why?
|
| Orthopedics | 1 | 2011 | 906 | 0.050 |
Why?
|
| Hypercalcemia | 1 | 1985 | 424 | 0.050 |
Why?
|
| Review Literature as Topic | 1 | 2004 | 298 | 0.050 |
Why?
|
| Osteomalacia | 1 | 2002 | 60 | 0.050 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2002 | 163 | 0.050 |
Why?
|
| Sulfates | 1 | 2002 | 379 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2005 | 1990 | 0.050 |
Why?
|
| Sulfonamides | 1 | 2011 | 1981 | 0.050 |
Why?
|
| RNA | 2 | 2005 | 2727 | 0.050 |
Why?
|
| Reference Values | 2 | 2010 | 4940 | 0.050 |
Why?
|
| Masseter Muscle | 1 | 2001 | 38 | 0.050 |
Why?
|
| Craniofacial Dysostosis | 1 | 1981 | 74 | 0.050 |
Why?
|
| Bone Development | 2 | 1998 | 473 | 0.050 |
Why?
|
| Stress, Mechanical | 2 | 2003 | 1680 | 0.050 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2005 | 627 | 0.050 |
Why?
|
| Calcium | 6 | 1999 | 5792 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 3726 | 0.040 |
Why?
|
| Polymethyl Methacrylate | 1 | 2001 | 132 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2012 | 3139 | 0.040 |
Why?
|
| Mandibular Diseases | 1 | 1981 | 117 | 0.040 |
Why?
|
| Titanium | 1 | 2003 | 495 | 0.040 |
Why?
|
| Knee | 1 | 2002 | 278 | 0.040 |
Why?
|
| Warfarin | 3 | 1991 | 1493 | 0.040 |
Why?
|
| Povidone | 1 | 1980 | 31 | 0.040 |
Why?
|
| Calcium Phosphates | 1 | 2001 | 173 | 0.040 |
Why?
|
| Nasal Bone | 1 | 1980 | 58 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 1999 | 6131 | 0.040 |
Why?
|
| Adolescent | 11 | 2013 | 89244 | 0.040 |
Why?
|
| Polyethylene | 1 | 2001 | 187 | 0.040 |
Why?
|
| Core Binding Factors | 1 | 1999 | 29 | 0.040 |
Why?
|
| Povidone-Iodine | 1 | 1980 | 56 | 0.040 |
Why?
|
| Accidental Falls | 1 | 2008 | 1080 | 0.040 |
Why?
|
| Risk Factors | 4 | 2011 | 74976 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2011 | 22296 | 0.040 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2020 | 110 | 0.040 |
Why?
|
| Bone Cements | 1 | 2001 | 327 | 0.040 |
Why?
|
| Nutritional Status | 1 | 2008 | 1627 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2021 | 2884 | 0.040 |
Why?
|
| Cell Movement | 2 | 2005 | 5216 | 0.040 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 1999 | 160 | 0.040 |
Why?
|
| Absorbable Implants | 1 | 2001 | 338 | 0.040 |
Why?
|
| Adrenal Glands | 1 | 2001 | 557 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2001 | 945 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2010 | 15951 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2012 | 3836 | 0.040 |
Why?
|
| Mouth Mucosa | 1 | 2001 | 437 | 0.040 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2020 | 260 | 0.040 |
Why?
|
| Bioreactors | 1 | 2000 | 246 | 0.040 |
Why?
|
| Cell Communication | 1 | 1986 | 1660 | 0.040 |
Why?
|
| Lymphangioma | 3 | 1983 | 60 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2007 | 14752 | 0.040 |
Why?
|
| Porifera | 1 | 1998 | 32 | 0.040 |
Why?
|
| Decalcification Technique | 2 | 1992 | 6 | 0.040 |
Why?
|
| Integrin alpha2 | 1 | 1998 | 39 | 0.040 |
Why?
|
| Interleukin-11 | 1 | 1998 | 59 | 0.040 |
Why?
|
| Cell Count | 3 | 1997 | 1833 | 0.040 |
Why?
|
| Prevalence | 2 | 2008 | 15879 | 0.040 |
Why?
|
| Surface Properties | 1 | 2001 | 1169 | 0.040 |
Why?
|
| Phenylmethylsulfonyl Fluoride | 1 | 1997 | 6 | 0.040 |
Why?
|
| Cocaine | 1 | 2003 | 947 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 4 | 1 | 1997 | 24 | 0.040 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 2001 | 227 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 1997 | 28 | 0.040 |
Why?
|
| Veins | 1 | 1982 | 769 | 0.040 |
Why?
|
| Antioxidants | 1 | 2005 | 1673 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 1 | 2004 | 1614 | 0.040 |
Why?
|
| Recovery of Function | 2 | 2008 | 2990 | 0.040 |
Why?
|
| HT29 Cells | 1 | 2017 | 190 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2000 | 588 | 0.040 |
Why?
|
| Dental Implantation, Endosseous | 1 | 2001 | 535 | 0.040 |
Why?
|
| Synovitis, Pigmented Villonodular | 1 | 1997 | 32 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2008 | 2960 | 0.040 |
Why?
|
| Ovary | 1 | 2001 | 965 | 0.030 |
Why?
|
| Transferrin | 1 | 1998 | 284 | 0.030 |
Why?
|
| Keratinocytes | 1 | 2001 | 876 | 0.030 |
Why?
|
| Giant Cell Tumors | 1 | 1997 | 89 | 0.030 |
Why?
|
| Phenotype | 4 | 2005 | 16731 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 3 | 1984 | 1629 | 0.030 |
Why?
|
| Arteries | 1 | 1982 | 1126 | 0.030 |
Why?
|
| Osteonecrosis | 1 | 1998 | 230 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 10765 | 0.030 |
Why?
|
| Blood Vessels | 1 | 1982 | 1110 | 0.030 |
Why?
|
| Body Composition | 2 | 2012 | 2462 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2004 | 1658 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2011 | 24333 | 0.030 |
Why?
|
| Follow-Up Studies | 5 | 2003 | 39394 | 0.030 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1996 | 205 | 0.030 |
Why?
|
| Heparin | 1 | 1983 | 1636 | 0.030 |
Why?
|
| Surgery, Plastic | 4 | 1985 | 651 | 0.030 |
Why?
|
| Alveolar Process | 2 | 1990 | 295 | 0.030 |
Why?
|
| Hydrocortisone | 3 | 2007 | 1841 | 0.030 |
Why?
|
| Collagen Type I | 1 | 1999 | 620 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2011 | 3811 | 0.030 |
Why?
|
| DNA Primers | 1 | 2000 | 2827 | 0.030 |
Why?
|
| Culture Techniques | 1 | 1996 | 530 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2003 | 2942 | 0.030 |
Why?
|
| Methods | 3 | 1998 | 1066 | 0.030 |
Why?
|
| Hemostatics | 1 | 1998 | 246 | 0.030 |
Why?
|
| Selenium | 1 | 1998 | 418 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2008 | 3443 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 1998 | 1500 | 0.030 |
Why?
|
| Tissue Donors | 2 | 2017 | 2382 | 0.030 |
Why?
|
| Cell Size | 1 | 1996 | 626 | 0.030 |
Why?
|
| Linear Models | 1 | 2004 | 5891 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2016 | 478 | 0.030 |
Why?
|
| Receptors, Calcitonin | 2 | 1997 | 34 | 0.030 |
Why?
|
| Protease Inhibitors | 1 | 1997 | 752 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2001 | 2126 | 0.030 |
Why?
|
| Bony Callus | 2 | 2003 | 41 | 0.030 |
Why?
|
| Radioimmunoassay | 2 | 2007 | 862 | 0.030 |
Why?
|
| Infant | 8 | 2004 | 36556 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 18068 | 0.030 |
Why?
|
| DNA | 3 | 2001 | 7214 | 0.030 |
Why?
|
| Embryonic and Fetal Development | 1 | 1994 | 420 | 0.030 |
Why?
|
| Child, Preschool | 8 | 2004 | 42683 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 3 | 1997 | 6232 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 1994 | 521 | 0.030 |
Why?
|
| Tendons | 1 | 1997 | 557 | 0.030 |
Why?
|
| Steroids | 1 | 1998 | 938 | 0.030 |
Why?
|
| Radiation Chimera | 1 | 1992 | 216 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 693 | 0.030 |
Why?
|
| Skin Neoplasms | 2 | 1982 | 5864 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2004 | 3450 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 1996 | 2018 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 1998 | 1197 | 0.020 |
Why?
|
| Transcription Factors | 2 | 2004 | 12174 | 0.020 |
Why?
|
| Apoptosis | 1 | 2008 | 9527 | 0.020 |
Why?
|
| Apatites | 1 | 1991 | 19 | 0.020 |
Why?
|
| Haversian System | 1 | 2010 | 9 | 0.020 |
Why?
|
| Spectrophotometry, Infrared | 1 | 1991 | 117 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2020 | 2228 | 0.020 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 2862 | 0.020 |
Why?
|
| Hematoxylin | 1 | 2010 | 61 | 0.020 |
Why?
|
| Eosine Yellowish-(YS) | 1 | 2010 | 70 | 0.020 |
Why?
|
| Freeze Drying | 2 | 1981 | 97 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1994 | 2474 | 0.020 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 2011 | 87 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2011 | 515 | 0.020 |
Why?
|
| Osteotomy, Le Fort | 1 | 2010 | 95 | 0.020 |
Why?
|
| Periosteum | 1 | 2010 | 139 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2017 | 2365 | 0.020 |
Why?
|
| Genes | 1 | 1994 | 1824 | 0.020 |
Why?
|
| Ligands | 1 | 2017 | 3283 | 0.020 |
Why?
|
| Radiation, Ionizing | 1 | 2010 | 252 | 0.020 |
Why?
|
| Rats, Mutant Strains | 1 | 1989 | 60 | 0.020 |
Why?
|
| Durapatite | 1 | 1990 | 167 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2007 | 13055 | 0.020 |
Why?
|
| Comorbidity | 1 | 2003 | 10592 | 0.020 |
Why?
|
| Spin Labels | 1 | 2010 | 339 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2010 | 877 | 0.020 |
Why?
|
| X-Ray Microtomography | 1 | 2011 | 457 | 0.020 |
Why?
|
| Young Adult | 2 | 2017 | 60131 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2008 | 81903 | 0.020 |
Why?
|
| Hospitalization | 1 | 2008 | 10847 | 0.020 |
Why?
|
| Coloring Agents | 1 | 2010 | 564 | 0.020 |
Why?
|
| Ribs | 2 | 1994 | 259 | 0.020 |
Why?
|
| Antigens, CD | 1 | 1998 | 4032 | 0.020 |
Why?
|
| Blood Urea Nitrogen | 1 | 2007 | 189 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2001 | 7609 | 0.020 |
Why?
|
| Inappropriate ADH Syndrome | 1 | 2007 | 59 | 0.020 |
Why?
|
| Peptides | 1 | 1999 | 4353 | 0.020 |
Why?
|
| Recurrence | 1 | 1999 | 8513 | 0.020 |
Why?
|
| Menopause | 1 | 1995 | 1656 | 0.020 |
Why?
|
| Particle Size | 1 | 2010 | 1652 | 0.020 |
Why?
|
| Body Weight | 1 | 2017 | 4628 | 0.020 |
Why?
|
| Random Allocation | 1 | 2010 | 2394 | 0.020 |
Why?
|
| Trace Elements | 1 | 1987 | 193 | 0.020 |
Why?
|
| Amifostine | 1 | 2005 | 40 | 0.020 |
Why?
|
| Testosterone | 1 | 2017 | 2493 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 1989 | 1755 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2011 | 3057 | 0.020 |
Why?
|
| Incidence | 1 | 2003 | 21547 | 0.020 |
Why?
|
| Creatine Kinase | 1 | 2007 | 684 | 0.020 |
Why?
|
| History, 17th Century | 1 | 1985 | 108 | 0.020 |
Why?
|
| Cell Nucleus | 2 | 2001 | 2885 | 0.020 |
Why?
|
| Prolactin | 1 | 2007 | 627 | 0.020 |
Why?
|
| Hand Strength | 1 | 2008 | 466 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2003 | 65480 | 0.010 |
Why?
|
| History, 18th Century | 1 | 1985 | 206 | 0.010 |
Why?
|
| Humerus | 1 | 1986 | 273 | 0.010 |
Why?
|
| Transplantation, Isogeneic | 2 | 1981 | 249 | 0.010 |
Why?
|
| Mutation | 1 | 1989 | 30266 | 0.010 |
Why?
|
| Transplantation, Heterologous | 2 | 1984 | 2395 | 0.010 |
Why?
|
| Alveoloplasty | 1 | 1983 | 21 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 1994 | 2634 | 0.010 |
Why?
|
| England | 1 | 1985 | 533 | 0.010 |
Why?
|
| Pliability | 1 | 2003 | 58 | 0.010 |
Why?
|
| Insulin | 1 | 1998 | 6610 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2003 | 26428 | 0.010 |
Why?
|
| Endothelium | 1 | 1986 | 768 | 0.010 |
Why?
|
| Polyhydroxyethyl Methacrylate | 1 | 1983 | 30 | 0.010 |
Why?
|
| Brain Edema | 1 | 2007 | 607 | 0.010 |
Why?
|
| History, 19th Century | 1 | 1985 | 715 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2010 | 1933 | 0.010 |
Why?
|
| Equipment Design | 1 | 2010 | 3530 | 0.010 |
Why?
|
| Methylene Chloride | 1 | 1982 | 11 | 0.010 |
Why?
|
| Clodronic Acid | 1 | 1982 | 60 | 0.010 |
Why?
|
| Langerhans Cells | 1 | 1982 | 169 | 0.010 |
Why?
|
| Glutaral | 1 | 2001 | 78 | 0.010 |
Why?
|
| Chromatography, Agarose | 1 | 1981 | 29 | 0.010 |
Why?
|
| Hypertelorism | 1 | 1981 | 29 | 0.010 |
Why?
|
| Fishes | 1 | 1985 | 606 | 0.010 |
Why?
|
| Ear Cartilage | 1 | 1981 | 62 | 0.010 |
Why?
|
| Microarray Analysis | 1 | 2004 | 755 | 0.010 |
Why?
|
| Phosphates | 1 | 1985 | 765 | 0.010 |
Why?
|
| Isoxsuprine | 1 | 1980 | 2 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1981 | 293 | 0.010 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2003 | 619 | 0.010 |
Why?
|
| Oxidation-Reduction | 2 | 2005 | 2226 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2003 | 41808 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2003 | 1379 | 0.010 |
Why?
|
| Arteriovenous Malformations | 1 | 1983 | 396 | 0.010 |
Why?
|
| Chemical Phenomena | 2 | 1998 | 486 | 0.010 |
Why?
|
| Drug Implants | 1 | 1981 | 230 | 0.010 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2001 | 287 | 0.010 |
Why?
|
| Internal Fixators | 1 | 2001 | 184 | 0.010 |
Why?
|
| Femur | 1 | 1986 | 1321 | 0.010 |
Why?
|
| Mice, Knockout | 2 | 2005 | 14484 | 0.010 |
Why?
|
| Dogs | 1 | 1984 | 3845 | 0.010 |
Why?
|
| Parathyroid Glands | 1 | 1982 | 522 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2011 | 3335 | 0.010 |
Why?
|
| Computational Biology | 1 | 2011 | 3562 | 0.010 |
Why?
|
| Patella | 1 | 1981 | 317 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1981 | 1309 | 0.010 |
Why?
|
| Menstrual Cycle | 1 | 2003 | 546 | 0.010 |
Why?
|
| Macrophages | 2 | 1986 | 5801 | 0.010 |
Why?
|
| Tensile Strength | 1 | 1980 | 335 | 0.010 |
Why?
|
| Proteins | 1 | 1994 | 6011 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1981 | 1435 | 0.010 |
Why?
|
| Face | 1 | 1984 | 1031 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 2001 | 692 | 0.010 |
Why?
|
| Chemistry, Physical | 1 | 1998 | 153 | 0.010 |
Why?
|
| Europe | 1 | 1985 | 3441 | 0.010 |
Why?
|
| Wound Infection | 1 | 1980 | 243 | 0.010 |
Why?
|
| Vitronectin | 1 | 1997 | 40 | 0.010 |
Why?
|
| Immune Sera | 1 | 1997 | 605 | 0.010 |
Why?
|
| Viscosity | 1 | 1998 | 334 | 0.010 |
Why?
|
| Abnormalities, Multiple | 1 | 1984 | 1423 | 0.010 |
Why?
|
| History, 20th Century | 1 | 1985 | 2771 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1997 | 1057 | 0.010 |
Why?
|
| Congenital Abnormalities | 1 | 1981 | 704 | 0.010 |
Why?
|
| Premenopause | 1 | 2000 | 1039 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1997 | 1065 | 0.010 |
Why?
|
| DNA Replication | 1 | 1983 | 1428 | 0.010 |
Why?
|
| HLA-DR Antigens | 1 | 1997 | 609 | 0.010 |
Why?
|
| Cleft Palate | 1 | 1981 | 597 | 0.010 |
Why?
|
| Sheep | 1 | 1998 | 1451 | 0.010 |
Why?
|
| Angiography | 1 | 1980 | 1598 | 0.010 |
Why?
|
| Spinal Fusion | 1 | 1984 | 1313 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 1982 | 1541 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1994 | 341 | 0.010 |
Why?
|
| Antigens, Viral, Tumor | 1 | 1994 | 153 | 0.010 |
Why?
|
| Simian virus 40 | 1 | 1994 | 292 | 0.010 |
Why?
|
| Cicatrix | 1 | 1980 | 799 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1997 | 1904 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 1994 | 224 | 0.010 |
Why?
|
| Arteriosclerosis | 1 | 1998 | 1056 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1994 | 777 | 0.010 |
Why?
|
| Cell Transformation, Viral | 1 | 1994 | 530 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 1997 | 17629 | 0.010 |
Why?
|
| Graft Survival | 2 | 1981 | 3888 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1982 | 3659 | 0.010 |
Why?
|
| Monocytes | 1 | 1982 | 2603 | 0.010 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 1994 | 327 | 0.010 |
Why?
|
| Oxytetracycline | 1 | 1991 | 11 | 0.010 |
Why?
|
| Surgical Flaps | 1 | 1980 | 1682 | 0.010 |
Why?
|
| Hand | 1 | 1997 | 913 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1994 | 1683 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 1982 | 3702 | 0.010 |
Why?
|
| Androgens | 1 | 1998 | 1285 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2003 | 6002 | 0.010 |
Why?
|
| Diet | 1 | 1987 | 8088 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 1987 | 5716 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1994 | 4168 | 0.000 |
Why?
|
| Knee Joint | 1 | 1997 | 1685 | 0.000 |
Why?
|
| Glycerophosphates | 1 | 1987 | 51 | 0.000 |
Why?
|
| Whole-Body Irradiation | 1 | 1987 | 435 | 0.000 |
Why?
|
| Gene Deletion | 1 | 1994 | 2674 | 0.000 |
Why?
|
| Phosphorus | 1 | 1987 | 336 | 0.000 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1994 | 3744 | 0.000 |
Why?
|
| Protein Binding | 1 | 1974 | 9344 | 0.000 |
Why?
|
| Microradiography | 1 | 1980 | 13 | 0.000 |
Why?
|
| Facial Injuries | 1 | 1981 | 191 | 0.000 |
Why?
|
| Physical Examination | 1 | 1983 | 1262 | 0.000 |
Why?
|
| Necrosis | 1 | 1980 | 1620 | 0.000 |
Why?
|
| Hematoma | 1 | 1980 | 768 | 0.000 |
Why?
|
| Dihydroxycholecalciferols | 1 | 1974 | 17 | 0.000 |
Why?
|
| Hydroxycholecalciferols | 1 | 1974 | 44 | 0.000 |
Why?
|
| Chemistry | 1 | 1974 | 327 | 0.000 |
Why?
|
| Tritium | 1 | 1974 | 707 | 0.000 |
Why?
|
| Rickets | 1 | 1974 | 70 | 0.000 |
Why?
|
| Chromatography, Gel | 1 | 1974 | 637 | 0.000 |
Why?
|
| Ergocalciferols | 1 | 1974 | 110 | 0.000 |
Why?
|
| Carbon Radioisotopes | 1 | 1974 | 567 | 0.000 |
Why?
|
| Solubility | 1 | 1974 | 1087 | 0.000 |
Why?
|
| Chickens | 1 | 1974 | 845 | 0.000 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1974 | 1731 | 0.000 |
Why?
|
| Biological Transport | 1 | 1974 | 2085 | 0.000 |
Why?
|
| Blood Proteins | 1 | 1974 | 1191 | 0.000 |
Why?
|